Literature DB >> 15215286

The role of 5-hydroxytryptamine3 receptors in the vagal afferent activation-induced inhibition of the first cervical dorsal horn spinal neurons projected from tooth pulp in the rat.

Takeshi Tanimoto1, Mamoru Takeda, Toshimi Nishikawa, Shigeji Matsumoto.   

Abstract

To test the hypothesis that vagal afferent (VA) stimulation modulates the first cervical dorsal horn (C(1)) neuron activity, which is projected by tooth pulp (TP) afferent inputs through the activation of a local GABAergic mechanism via 5-hydroxytryptamine(3) (5-HT(3)) receptors, we used the technique of microiontophoretic application of drugs. In pentobarbital-anesthetized rats, we recorded C(1) spinal neuron activity responding to TP stimulation. The TP stimulation-evoked C(1) spinal neuron excitation was inhibited by VA stimulation, and this inhibition was significantly attenuated by iontophoretic application of the 5-HT(3) receptor antagonist ICS 205-930 (3-tropanyl-indole-3-carboxylate hydrochloride [endo-8-methyl-8-azabicyclo [3.2.1] oct-3-ol indol-3-yl-carboxylate hydrochloride]) (40 nA) or the GABA(A) receptor antagonist bicuculline (40 nA). In another series of experiments, we determined that 60 nA iontophoretic application of glutamate produced a maximal increase in the C(1) spinal neuron activity at a minimal current. In 53 of 65 neurons (81.5%), VA conditioning stimulation (1.0 mA x 0.1 ms, 50 Hz for 30 s) caused a significant inhibition (35.1%) of the glutamate (60 nA) application-evoked C(1) spinal neuron excitation. Iontophoretic application of ICS 205-930 (40 nA) or bicuculline (40 nA) significantly attenuated the VA stimulation-induced inhibition of glutamate iontophoretic application (60 nA)-evoked C(1) spinal neuron excitation. These results suggest that VA stimulation-induced suppression of C(1) spinal neuron activity, responding to TP stimulation, involve 5-HT(3) receptor activation, possibly originating in the descending serotonergic inhibitory system, and postsynaptic modulation of inhibitory GABAergic neurons.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15215286     DOI: 10.1124/jpet.104.070300

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  6 in total

1.  Modulation of human 5-hydroxytryptamine type 3AB receptors by volatile anesthetics and n-alcohols.

Authors:  Renna Stevens; Dirk Rüsch; Ken Solt; Douglas E Raines; Paul A Davies
Journal:  J Pharmacol Exp Ther       Date:  2005-04-14       Impact factor: 4.030

2.  Activation of alpha2-adrenoreceptors suppresses the excitability of C1 spinal neurons having convergent inputs from tooth pulp and superior sagittal sinus in rats.

Authors:  M Takeda; T Tanimoto; M Takahashi; J Kadoi; M Nasu; S Matsumoto
Journal:  Exp Brain Res       Date:  2006-04-08       Impact factor: 1.972

3.  The dietary constituent resveratrol suppresses nociceptive neurotransmission via the NMDA receptor.

Authors:  Shiori Takehana; Yoshiko Kubota; Nobuo Uotsu; Kei Yui; Koichi Iwata; Yoshihito Shimazu; Mamoru Takeda
Journal:  Mol Pain       Date:  2017-01       Impact factor: 3.395

Review 4.  Modulatory Mechanism of Nociceptive Neuronal Activity by Dietary Constituent Resveratrol.

Authors:  Mamoru Takeda; Shiori Takehana; Kenta Sekiguchi; Yoshiko Kubota; Yoshihito Shimazu
Journal:  Int J Mol Sci       Date:  2016-10-11       Impact factor: 5.923

5.  Noninvasive vagus nerve stimulation and morphine transiently inhibit trigeminal pain signaling in a chronic headache model.

Authors:  Lauren E Cornelison; Jordan L Hawkins; Sara E Woodman; Paul L Durham
Journal:  Pain Rep       Date:  2020-12-17

6.  Inhibition of Trigeminal Nociception by Non-invasive Vagus Nerve Stimulation: Investigating the Role of GABAergic and Serotonergic Pathways in a Model of Episodic Migraine.

Authors:  Lauren E Cornelison; Sara E Woodman; Paul L Durham
Journal:  Front Neurol       Date:  2020-03-05       Impact factor: 4.003

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.